{"slideshow_credits": null, "snippet": "Sex and drug claims at Jefferies draw a risky retort. | JPMorgan lifts its estimate for legal costs. | Tough quarter for Sprint highlights lost promise of T-Mobile US deal.", "abstract": "Sex and drug claims at Jefferies draw a risky retort. | JPMorgan lifts its estimate for legal costs. | Tough quarter for Sprint highlights lost promise of T-Mobile US deal.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Sydney", "role": "reported", "lastname": "EMBER", "rank": 1, "organization": ""}], "original": "By SYDNEY EMBER"}, "web_url": "http://dealbook.nytimes.com/2014/11/04/morning-agenda-sex-drugs-and-investment-banking/", "lead_paragraph": null, "headline": {"main": "Morning Agenda: Sex, Drugs and Investment Banking", "kicker": "DealBook"}, "_id": "5458c7ea38f0d8086c45ec67", "word_count": "0", "multimedia": [], "pub_date": "2014-11-04T07:29:55Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}